Speaker
Mark Shulewitz
When and where
Starts: Monday, 21 April 2025 - 10:00
Ends: Monday, 21 April 2025 - 11:00
Location:
Xtalks, Toronto, Canada
Location details: Free Registration on Xtalks.com
Event description
Small nucleic acid drugs, such as siRNA, anti-sense oligonucleotides (ASO), miRNA and aptamers, function by binding to and inhibit the activity of RNA through a process known as RNA interference (RNAi).
This class of molecules offer many advantages over traditional pharmaceuticals: unlimited target selection, high specificity, long half-life, ease of design and fast development and production processes.
In this webinar, the expert speaker will discuss recent advances in the development of small nucleic acid drugs and explain how a one-stop solution from design and synthesis to analysis, screening, verification and delivery can accelerate research.
The key topics will include:
- The different modalities of small nucleic acid drugs and their latest advances
- The major challenges in the development of small nucleic acid drugs and how they are being solved
- Case studies demonstrating the advantages in obtaining candidates having high knockdown efficiency
Register for this webinar today to explore the latest breakthroughs in small nucleic acid drug development.
Further details
IMPORTANT: In order to register to this free webinar you must register directly on Xtalks via the following URL: https://xtalks.com/webinars/advancing-small-nucleic-acid-drug-development-with-a-one-stop-solution/
Geolocation will be visible after you sign in.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 57
- Comments 0